On Monday, Solaris Energy Infr got an upgrade for its IBD SmartSelect Composite Rating from 94 to 97.
Looking For The Best Stocks To Buy And Watch? Start Here
The new score indicates the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. Winning stocks often have a 95 or higher grade in the early stages of a new price run, so that's a good item to have on your checklist when looking for the best stocks to buy and watch.
Solaris Energy Infr is currently extended beyond a proper buy zone after breaking out from a 13.56 entry in a consolidation.
The stock earns an 84 EPS Rating, which means its recent quarterly and annual earnings growth tops 84% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported 25% earnings-per-share growth for Q1. That means it's now generated two straight quarters of rising EPS growth. Revenue growth rose 86%, up from 52% in the prior report. That marks five quarters of increasing revenue gains.
Solaris Energy Infr earns the No. 2 rank among its peers in the Chemicals-Specialty industry group. Niagen Bioscience is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
